Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Shayahati Bieerkehazhi(The University of Texas Health Science Center at Houston), Jianhua Yang(Sun Yat-sen University)
Oncotarget
November 26, 2016
Cited by 39


Related Papers